Literature DB >> 34340015

Serine ADP-ribosylation in DNA-damage response regulation.

Luca Palazzo1, Marcin J Suskiewicz2, Ivan Ahel3.   

Abstract

PARP1 and PARP2 govern the DNA-damage response by catalysing the reversible post-translational modification ADP-ribosylation. During the repair of DNA lesions, PARP1 and PARP2 combine with an accessory factor HPF1, which is required for the modification of target proteins on serine residues. Although the physiological role of individual ADP-ribosylation sites is still unclear, serine ADP-ribosylation at damage sites leads to the recruitment of chromatin remodellers and repair factors to ensure efficient DNA repair. ADP-ribosylation signalling is tightly controlled by the coordinated activities of (ADP-ribosyl)glycohydrolases PARG and ARH3 that, by reversing the modification, guarantee proper kinetics of DNA repair and cell cycle re-entry. The recent advances in the structural and mechanistic understanding of ADP-ribosylation provide new insights into human physiopathology and cancer therapy.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34340015     DOI: 10.1016/j.gde.2021.07.005

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  6 in total

Review 1.  Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).

Authors:  Anthony Sanchez; Bethany A Buck-Koehntop; Kyle M Miller
Journal:  Bioessays       Date:  2022-05-09       Impact factor: 4.653

2.  Mimetics of ADP-Ribosylated Histidine through Copper(I)-Catalyzed Click Chemistry.

Authors:  Hugo Minnee; Johannes G M Rack; Gijsbert A van der Marel; Herman S Overkleeft; Jeroen D C Codée; Ivan Ahel; Dmitri V Filippov
Journal:  Org Lett       Date:  2022-05-19       Impact factor: 6.072

3.  Beyond protein modification: the rise of non-canonical ADP-ribosylation.

Authors:  Marion Schuller; Ivan Ahel
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

4.  Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration.

Authors:  Lyndsay Hastings; Arpine Sokratian; Daniel J Apicco; Christina M Stanhope; Lindsey Smith; Warren D Hirst; Andrew B West; Kaela Kelly
Journal:  Brain Commun       Date:  2022-02-22

Review 5.  Are PARPs promiscuous?

Authors:  Karla L H Feijs; Roko Žaja
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.840

6.  The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.

Authors:  Francesco Morra; Francesco Merolla; Giovanna Damia; Francesca Ricci; Silvia Varricchio; Gennaro Ilardi; Laura Arenare; Daniela Califano; Virginia Napolitano; Robert Fruscio; Rosa Marina Melillo; Luca Palazzo; Angela Celetti
Journal:  J Exp Clin Cancer Res       Date:  2022-08-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.